Waldman R H, Grunspan R, Ganguly R
Infect Immun. 1972 Jul;6(1):58-61. doi: 10.1128/iai.6.1.58-61.1972.
A study was undertaken to assess the efficacy of oral, parenteral, and intraperitoneal immunization methods of administering killed Salmonella typhimurium vaccine to mice and to evaluate the effectiveness of single and multiple doses of the vaccine containing varied numbers of the killed bacteria. A further objective of this study was to evaluate the effect of adding substances to the vaccine to which have been ascribed "adjuvant" properties. The protection was estimated by isolation of bacteria from the spleen and feces after oral challenge of the mice with live S. typhimurium. The results showed that one or more doses of 10(10) organisms given orally led to significant protection. This rate of protection increased proportionately with the number of doses up to 10 doses, which offered 100% protection. Streptomycin, when added to multiple doses of 10(9) or more organisms given orally, increased the degree of protection, but beryllium sulfate and pertussis vaccine did not. Although multiple doses afforded similar systemic protection by all three routes of immunization, oral immunization yielded significantly greater local protection than that observed after subcutaneous or intraperitoneal immunization.
开展了一项研究,以评估对小鼠口服、注射及腹腔注射灭活鼠伤寒沙门氏菌疫苗的免疫效果,并评估含不同数量灭活细菌的单剂量和多剂量疫苗的有效性。本研究的另一个目的是评估向具有“佐剂”特性的疫苗中添加物质的效果。在用活的鼠伤寒沙门氏菌对小鼠进行口服攻击后,通过从脾脏和粪便中分离细菌来评估保护作用。结果表明,口服一剂或多剂10¹⁰个菌体能产生显著的保护作用。这种保护率随着剂量数增加到10剂而相应增加,10剂时提供100%的保护。口服多剂量10⁹个或更多菌体时添加链霉素可增加保护程度,但硫酸铍和百日咳疫苗则不然。虽然通过所有三种免疫途径多剂量都能提供类似的全身保护,但口服免疫产生的局部保护明显大于皮下或腹腔免疫后的局部保护。